Affordable Access

Publisher Website

lncRNA KIAA0125 functions as a tumor suppressor modulating growth and metastasis of colorectal cancer via Wnt/β-catenin pathway.

Authors
  • Yang, Yang1
  • Zhao, Yanan1
  • Hu, Nanjun1
  • Zhao, Jia2
  • Bai, Yuansong1
  • 1 Department of Oncology and Hematology, China-Japan Union Hospital of Jilin University, Changchun, 130033, Jilin, China. , (China)
  • 2 Department of Anesthesiology, China-Japan Union Hospital of Jilin University, Changchun, 130033, Jilin, China. , (China)
Type
Published Article
Journal
Cell Biology International
Publisher
Wiley (John Wiley & Sons)
Publication Date
Dec 01, 2019
Volume
43
Issue
12
Pages
1463–1470
Identifiers
DOI: 10.1002/cbin.11196
PMID: 31228314
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Colorectal cancer (CRC) is the third most common cancer in all races worldwide in recent years. The survival of the CRC patients is mostly affected by the stage of the disease at the time of diagnosis. Thus, the current challenge is to find sensitive and reliable biomarkers in early screening of CRC. Recently, emerging evidence has shown that long non-coding RNAs (lncRNAs) may play crucial roles in tumorigenesis. In this study, we found that lncRNA KIAA0125 was downregulated in colorectal tissues and cells. The functional study demonstrated that overexpression of KIAA0125 suppressed cell proliferation, migration, and invasion whereas the reversal effects were seen in silencing experiment. Besides, KIAA0125 inhibited epithelial-mesenchymal transition through Wnt/β-catenin signaling in CRC. Our findings suggested that KIAA0125 may act as an oncosupressor gene and could be considered as a potential diagnosis biomarker in CRC. © 2019 The Authors Cell Biology International published by John Wiley & Sons Ltd on behalf of International Federation of Cell Biology.

Report this publication

Statistics

Seen <100 times